These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21637010)

  • 81. Facilitating Earlier Diagnosis of Cardiovascular Disease through Point-of-Care Biosensors: A Review.
    Honikel MM; Lin CE; Probst D; La Belle JT
    Crit Rev Biomed Eng; 2018; 46(1):53-82. PubMed ID: 29717677
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Advancements and future directions in cardiac biomarker detection using lateral flow assays.
    Schuster da Silva S; Cunha ML; Ayres LB; Garcia CD; Blanes L
    Anal Methods; 2023 Aug; 15(30):3610-3630. PubMed ID: 37489903
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A review of biosensor technologies for blood biomarkers toward monitoring cardiovascular diseases at the point-of-care.
    Ouyang M; Tu D; Tong L; Sarwar M; Bhimaraj A; Li C; Coté GL; Di Carlo D
    Biosens Bioelectron; 2021 Jan; 171():112621. PubMed ID: 33120234
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Diagnostics on acute myocardial infarction: Cardiac troponin biomarkers.
    Fathil MF; Md Arshad MK; Gopinath SC; Hashim U; Adzhri R; Ayub RM; Ruslinda AR; Nuzaihan M N M; Azman AH; Zaki M; Tang TH
    Biosens Bioelectron; 2015 Aug; 70():209-20. PubMed ID: 25841117
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Programmable bio-nanochip technology for the diagnosis of cardiovascular disease at the point-of-care.
    Christodoulides N; Pierre FN; Sanchez X; Li L; Hocquard K; Patton A; Muldoon R; Miller CS; Ebersole JL; Redding S; Yeh CK; Furmaga WB; Wampler DA; Bozkurt B; Ballantyne CM; McDevitt JT
    Methodist Debakey Cardiovasc J; 2012 Jan; 8(1):6-12. PubMed ID: 22891104
    [TBL] [Abstract][Full Text] [Related]  

  • 86. High-sensitivity cardiac troponin assays: From improved analytical performance to enhanced risk stratification.
    Kozinski M; Krintus M; Kubica J; Sypniewska G
    Crit Rev Clin Lab Sci; 2017 May; 54(3):143-172. PubMed ID: 28457177
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Portable microfluidic and smartphone-based devices for monitoring of cardiovascular diseases at the point of care.
    Hu J; Cui X; Gong Y; Xu X; Gao B; Wen T; Lu TJ; Xu F
    Biotechnol Adv; 2016; 34(3):305-20. PubMed ID: 26898179
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Three-month outcome of patients with suspected acute coronary syndrome using point-of-care cardiac troponin-T testing compared with laboratory-based cardiac troponin-T testing: a randomised trial.
    Asha SE; Cooke A; Walter E; Weaver J
    Emerg Med J; 2015 Aug; 32(8):601-7. PubMed ID: 25261004
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Cardiac troponin I: a case study in rational antibody design for human diagnostics.
    Conroy PJ; O'Kennedy RJ; Hearty S
    Protein Eng Des Sel; 2012 Jun; 25(6):295-305. PubMed ID: 22509048
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Enabling miniaturised personalised diagnostics: from lab-on-a-chip to lab-in-a-drop.
    Koo KM; Wee EJH; Wang Y; Trau M
    Lab Chip; 2017 Sep; 17(19):3200-3220. PubMed ID: 28850136
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The clinical value of whole blood point-of-care biomarkers in large animal emergency and critical care medicine.
    Radcliffe RM; Buchanan BR; Cook VL; Divers TJ
    J Vet Emerg Crit Care (San Antonio); 2015; 25(1):138-51. PubMed ID: 25590562
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Ultrasensitive nanostructure sensor arrays on flexible substrates for multiplexed and simultaneous electrochemical detection of a panel of cardiac biomarkers.
    Radha Shanmugam N; Muthukumar S; Chaudhry S; Anguiano J; Prasad S
    Biosens Bioelectron; 2017 Mar; 89(Pt 2):764-772. PubMed ID: 27818043
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Antibody production, design and use for biosensor-based applications.
    Conroy PJ; Hearty S; Leonard P; O'Kennedy RJ
    Semin Cell Dev Biol; 2009 Feb; 20(1):10-26. PubMed ID: 19429487
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Immunosensors in Clinical Laboratory Diagnostics.
    Justino CI; Duarte AC; Rocha-Santos TA
    Adv Clin Chem; 2016; 73():65-108. PubMed ID: 26975970
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Evidence-based point-of-care diagnostics: current status and emerging technologies.
    Chan CP; Mak WC; Cheung KY; Sin KK; Yu CM; Rainer TH; Renneberg R
    Annu Rev Anal Chem (Palo Alto Calif); 2013; 6():191-211. PubMed ID: 23527548
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Prehospital point-of-care testing for troponin: are the results reliable?
    Venturini JM; Stake CE; Cichon ME
    Prehosp Emerg Care; 2013; 17(1):88-91. PubMed ID: 22954226
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Comparison of Point-of-Care Versus Laboratory Troponin Testing in an Emergency Department Setting.
    Juliano M; Wason C
    Mil Med; 2017 Jul; 182(7):e1938-e1940. PubMed ID: 28810994
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Blu-ray Technology-Based Quantitative Assays for Cardiac Markers: From Disc Activation to Multiplex Detection.
    Weng S; Li X; Niu M; Ge B; Yu HZ
    Anal Chem; 2016 Jul; 88(13):6889-96. PubMed ID: 27268387
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Cardiac markers and their point-of-care testing for diagnosis of acute myocardial infarction.
    Yang Z; Min Zhou D
    Clin Biochem; 2006 Aug; 39(8):771-80. PubMed ID: 16836992
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The Usefulness and Limitations of Point-of-care Cardiac Troponin Measurement in the Emergency Department.
    Suzuki K; Komukai K; Nakata K; Kang R; Oi Y; Muto E; Kashiwagi Y; Tominaga M; Miyanaga S; Ishikawa T; Okuno K; Uzura M; Yoshimura M
    Intern Med; 2018 Jun; 57(12):1673-1680. PubMed ID: 29434124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.